Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 101
interventional 78
Observational 18
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 25
Drug|placebo 17
Device 8
Procedure 8
Device|Procedure 5
Other 3
Diagnostic Test 2
Drug|Other 2
Behavioral 1
Behavioral|Other 1
Biological 1
Biological|Procedure 1
Device|Dietary Supplement|Drug 1
Drug|placebo|Procedure 1
Drug|Procedure 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 15
China 12
India 6
France 5
Germany 3
Italy 3
NA 3
Spain 3
United States|Canada 3
Canada 2
Denmark 2
Egypt 2
Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Hungary|Italy|Romania|Spain 1
Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Italy|Spain|Taiwan 1
Austria 1
Austria|France|Italy|Spain|United Kingdom 1
Belgium|Bulgaria|Germany|Spain 1
Brazil 1
Czech Republic 1
Dominican Republic 1
Finland 1
France|Belgium 1
France|Germany|Italy|Spain 1
Portugal 1
Sweden 1
United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Croatia|Denmark|France|Hungary|Israel|Italy|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Croatia|Czech Republic|France|Germany|Hungary|Italy|Romania|Spain 1
United States|Austria|Belgium|Canada|Hungary|India|Israel|Spain|United Kingdom 1
United States|Belgium|Denmark|France|Germany|Italy|Spain|United Kingdom 1
United States|Italy|Sweden 1

Sites per Study

Site_count Study_Count
1 44
2 4
3 3
4 4
6 5
7 1
8 2
9 2
10 1
11 1
12 1
13 2
18 1
19 1
21 1
22 1
26 1
33 1
46 1
122 1

Phase

Phase Study_Count
N/A 28
Phase 2 17
Phase 3 14
Phase 4 8
Phase 2/Phase 3 7
Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 22
2 40
3 7
4 3
5 1
NA 5

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.0000 11.00 4.00000 9.00000 33.0000 10.00
1st Qu. 53.7500 16.25 16.00000 40.00000 86.0000 26.75
Median 90.0000 24.00 53.00000 45.00000 152.0000 43.50
Mean 158.6071 24.75 94.64706 75.83333 202.6154 109.75
3rd Qu. 148.5000 32.50 151.00000 56.00000 230.0000 125.25
Max. 1000.0000 40.00 336.00000 258.00000 535.0000 431.00

Trial Group Type

group_type Group_Count
Experimental 72
Active Comparator 41
Placebo Comparator 15
No Intervention 6
Other 6
NA 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 48
Single Group Assignment 24
Crossover Assignment 3
Sequential Assignment 2
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 55
Supportive Care 7
Diagnostic 6
Prevention 5
NA 2
Basic Science 1
Health Services Research 1
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 4
France 3
NA 2
Austria 1
China 1
Egypt 1
Finland 1
Germany 1
Germany|Switzerland|United Kingdom 1
Italy 1
Mexico 1
Spain 1

Sites per Study

Site_count Study_Count
1 13
2 3
3 2

Enrollment Metrics

Measure Observational
Min 17.0000
1st Qu 37.0000
Median 100.0000
Mean 148.3889
3rd Qu 153.5000
Max 1000.0000

Observation Model

observational_model Study_Count
Cohort 8
Case-Control 3
Other 3
Case-Only 2
Defined Population, Natural History 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 12
Retrospective 3
Cross-Sectional 1
Cross-Sectional, Retrospective 1
Other 1

Registries

Studies by Country

Country Study_Count
Argentina|Australia|Austria|Belgium|Denmark|France|Germany|Italy|Poland|Russian Federation|Singapore|Spain|Switzerland 1
Austria 1
Germany|Switzerland 1
Korea, Republic of 1
Poland 1

Sites per Study

Site_count Study_Count
1 3
2 1
16 1

Enrollment Metrics

Measure Registries
Min 170
1st Qu 195
Median 400
Mean 2353
3rd Qu 1000
Max 10000

Registry Model

observational_model Study_Count
Cohort 5

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
2 Years 2
1 Year 1
10 Years 1
2 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT02799212 Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma by Laparotomy https://ClinicalTrials.gov/show/NCT02799212 Recruiting Hospices Civils de Lyon 2021-04-25
NCT02400164 A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites https://ClinicalTrials.gov/show/NCT02400164 Completed Sequana Medical N.V. 2018-01-19
NCT03475615 A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites https://ClinicalTrials.gov/show/NCT03475615 Recruiting Fudan University 2020-12-31
NCT03327688 Point-of-care Ultrasound in Finland https://ClinicalTrials.gov/show/NCT03327688 Recruiting Kuopio University Hospital 2019-07-31
NCT03191851 Evaluation of ‘Melody’ Paracentesis Device for Ascites Therapy https://ClinicalTrials.gov/show/NCT03191851 Completed University of Nottingham 2019-01-10
NCT03172273 Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites https://ClinicalTrials.gov/show/NCT03172273 Recruiting Fourth Military Medical University 2022-09-18
NCT03107091 Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites https://ClinicalTrials.gov/show/NCT03107091 Completed BioVie Inc. 2019-04-01
NCT03069131 Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites https://ClinicalTrials.gov/show/NCT03069131 Recruiting Centre Hospitalier Universitaire de Besancon 2020-11-30
NCT04032600 Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics https://ClinicalTrials.gov/show/NCT04032600 Recruiting Charite University, Berlin, Germany 2019-08-31
NCT02867293 Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial. https://ClinicalTrials.gov/show/NCT02867293 Completed Mansoura University 2016-01-31
NCT02821377 Metabolic Effects of Furosemide +HSS in Refractory Ascites https://ClinicalTrials.gov/show/NCT02821377 Completed University of Palermo 2015-12-31
NCT02787772 Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? https://ClinicalTrials.gov/show/NCT02787772 Completed University of Sao Paulo General Hospital 2014-11-30
NCT02608658 Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT02608658 Completed St. Louis University 2017-04-27
NCT01769040 Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT01769040 Completed Copenhagen University Hospital, Hvidovre 2016-01-31
NCT03506893 Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT03506893 Recruiting University Hospital, Grenoble 2020-04-01
NCT02173288 Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites https://ClinicalTrials.gov/show/NCT02173288 Completed Postgraduate Institute of Medical Education and Research 2016-03-31
NCT02122185 Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer https://ClinicalTrials.gov/show/NCT02122185 Recruiting University of Chicago 2021-02-25
NCT02120196 Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis https://ClinicalTrials.gov/show/NCT02120196 Recruiting Tanta University 2023-12-31
NCT02085915 Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis https://ClinicalTrials.gov/show/NCT02085915 Completed Centre Hospitalier Departemental Vendee 2015-08-31
NCT01288794 Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01288794 Completed University of Bologna 2014-11-30
NCT04315571 Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents https://ClinicalTrials.gov/show/NCT04315571 Recruiting University of California, Los Angeles 2023-01-01
NCT03493204 Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial https://ClinicalTrials.gov/show/NCT03493204 Completed University of Michigan 2019-08-19
NCT01528410 ALFApump System Versus Standard of Care in Ascites Treatment https://ClinicalTrials.gov/show/NCT01528410 Completed Sequana Medical N.V. 2016-09-21
NCT01440829 The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS https://ClinicalTrials.gov/show/NCT01440829 Completed Fourth Military Medical University 2012-12-31
NCT01403987 Improving Performance of Paracentesis in Medical Residency Training https://ClinicalTrials.gov/show/NCT01403987 Completed Boston Medical Center 2012-03-31
NCT01349348 Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites https://ClinicalTrials.gov/show/NCT01349348 Completed Otsuka Beijing Research Institute 2012-05-31
NCT01349335 Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT01349335 Completed Otsuka Beijing Research Institute 2010-01-31
NCT01359462 Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis https://ClinicalTrials.gov/show/NCT01359462 Completed Otsuka Beijing Research Institute 2009-11-30
NCT01327235 Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites https://ClinicalTrials.gov/show/NCT01327235 Completed Jiangsu Simcere Pharmaceutical Co., Ltd. 2014-04-30
NCT04232384 Comparison of "Roll-over’ Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis https://ClinicalTrials.gov/show/NCT04232384 Recruiting Postgraduate Institute of Medical Education and Research 2021-11-15
NCT00358878 Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) https://ClinicalTrials.gov/show/NCT00358878 Completed Sanofi 2008-12-31
NCT04245553 Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis? https://ClinicalTrials.gov/show/NCT04245553 Recruiting Queen’s University 2021-01-31
NCT04208776 Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites. https://ClinicalTrials.gov/show/NCT04208776 Recruiting Institute of Liver and Biliary Sciences, India 2020-12-31
NCT04058613 Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites https://ClinicalTrials.gov/show/NCT04058613 Recruiting Institute of Liver and Biliary Sciences, India 2020-08-08
NCT04051112 Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites https://ClinicalTrials.gov/show/NCT04051112 Recruiting Sichuan Clover Biopharmaceuticals, Inc. 2020-12-31
NCT04050683 Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS) https://ClinicalTrials.gov/show/NCT04050683 Enrolling by invitation Medical College of Wisconsin 2024-12-31
NCT04013074 Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites. https://ClinicalTrials.gov/show/NCT04013074 Recruiting Institute of Liver and Biliary Sciences, India 2020-07-31
NCT03990103 S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites https://ClinicalTrials.gov/show/NCT03990103 Recruiting China Medical University, China 2021-04-30
NCT03973866 Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) https://ClinicalTrials.gov/show/NCT03973866 Recruiting Sequana Medical N.V. 2021-07-31
NCT03827200 A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03827200 Recruiting Noorik Biopharmaceuticals AG 2020-09-30
NCT03682744 CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) https://ClinicalTrials.gov/show/NCT03682744 Active, not recruiting Sorrento Therapeutics, Inc. 2020-09-30
NCT03451292 Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites https://ClinicalTrials.gov/show/NCT03451292 Recruiting Grifols Therapeutics LLC 2021-10-31
NCT00006166 North American Study for the Treatment of Refractory Ascites (NASTRA) https://ClinicalTrials.gov/show/NCT00006166 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT01292304 Tolvaptan for Ascites in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01292304 Completed University of Florida 2014-12-31
NCT01200121 Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT01200121 Completed AIO-Studien-gGmbH 2014-08-31
NCT01150916 B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites https://ClinicalTrials.gov/show/NCT01150916 Completed University of Sao Paulo 2011-11-30
NCT01188746 Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites https://ClinicalTrials.gov/show/NCT01188746 Completed Memorial Sloan Kettering Cancer Center 2020-02-29
NCT00327444 Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites https://ClinicalTrials.gov/show/NCT00327444 Completed Sanofi 2009-10-31
NCT01065246 Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites https://ClinicalTrials.gov/show/NCT01065246 Completed Neovii Biotech 2011-04-30
NCT01059396 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal https://ClinicalTrials.gov/show/NCT01059396 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2015-07-15
NCT00986817 Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin https://ClinicalTrials.gov/show/NCT00986817 Completed Assistance Publique - Hôpitaux de Paris 2015-03-31
NCT00968695 Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. https://ClinicalTrials.gov/show/NCT00968695 Completed Grifols Therapeutics LLC 2014-04-30
NCT00907673 The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure https://ClinicalTrials.gov/show/NCT00907673 Completed NovaShunt AG 2010-03-31
NCT00870662 A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal https://ClinicalTrials.gov/show/NCT00870662 Completed NovaShunt AG 2009-12-31
NCT04221672 The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy https://ClinicalTrials.gov/show/NCT04221672 Recruiting Shanghai Zhongshan Hospital 2020-12-30
NCT01179607 Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia https://ClinicalTrials.gov/show/NCT01179607 Completed Movetis 2007-12-31
NCT00947336 Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics https://ClinicalTrials.gov/show/NCT00947336 Completed Govind Ballabh Pant Hospital 2008-04-30
NCT00836654 Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group https://ClinicalTrials.gov/show/NCT00836654 Completed Neovii Biotech 2006-11-30
NCT00822809 CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers https://ClinicalTrials.gov/show/NCT00822809 Completed Neovii Biotech 2010-11-30
NCT04322201 Continuous Passive Paracentesis for Intra-abdominal Hypertension https://ClinicalTrials.gov/show/NCT04322201 Recruiting Centro Hospitalar de Lisboa Central 2021-11-30
NCT02638051 Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT https://ClinicalTrials.gov/show/NCT02638051 Completed Galenic Research Institute Ltd 2014-12-31
NCT04384523 A Study of OsrHSA in Adult Healthy Male and Female Volunteers https://ClinicalTrials.gov/show/NCT04384523 Completed Healthgen Biotechnology Corp. 2020-03-17
NCT04125654 Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases https://ClinicalTrials.gov/show/NCT04125654 Recruiting Nanfang Hospital of Southern Medical University 2020-08-30
NCT00741663 Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) https://ClinicalTrials.gov/show/NCT00741663 Completed University of Padova 2008-09-30
NCT00591968 Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community https://ClinicalTrials.gov/show/NCT00591968 Completed Edward Via Virginia College of Osteopathic Medicine 2008-03-31
NCT00570622 Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis https://ClinicalTrials.gov/show/NCT00570622 Completed Medical University of Vienna 2008-11-30
NCT00501722 Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites https://ClinicalTrials.gov/show/NCT00501722 Completed Sanofi 2005-03-31
NCT00501384 Satavaptan Dose-Ranging Study in the Prevention of Ascites https://ClinicalTrials.gov/show/NCT00501384 Completed Sanofi 2005-05-31
NCT01030185 Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance https://ClinicalTrials.gov/show/NCT01030185 Completed NovaShunt AG 2011-11-30
NCT00396591 AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites https://ClinicalTrials.gov/show/NCT00396591 Completed Sanofi 2008-11-30
NCT00326885 Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites https://ClinicalTrials.gov/show/NCT00326885 Completed Neovii Biotech 2009-12-31
NCT00240045 The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction https://ClinicalTrials.gov/show/NCT00240045 Completed University of Alberta NA
NCT00222014 TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT00222014 Completed University Hospital, Toulouse 2012-12-31
NCT00182754 Octreotide in Treating Patients With Cancer-Related Malignant Ascites https://ClinicalTrials.gov/show/NCT00182754 Completed Alliance for Clinical Trials in Oncology 2009-09-30
NCT00115947 Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites https://ClinicalTrials.gov/show/NCT00115947 Completed Hvidovre University Hospital NA
NCT00108355 Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis https://ClinicalTrials.gov/show/NCT00108355 Completed VA Office of Research and Development 2010-08-31
NCT00501566 Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites https://ClinicalTrials.gov/show/NCT00501566 Completed Sanofi NA
NCT00005906 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis https://ClinicalTrials.gov/show/NCT00005906 Completed National Institutes of Health Clinical Center (CC) 2008-04-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03200106 Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites https://ClinicalTrials.gov/show/NCT03200106 Completed Sequana Medical N.V. 2018-02-28
NCT04279327 Cell Block Immunohistochemistry in Effusion Cytology https://ClinicalTrials.gov/show/NCT04279327 Recruiting Assiut University 2021-04-30
NCT03189108 Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors https://ClinicalTrials.gov/show/NCT03189108 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2027-01-04
NCT02996188 Acute Hemodynamic Changes During Paracentesis https://ClinicalTrials.gov/show/NCT02996188 Completed Universitätsmedizin Mannheim 2013-11-30
NCT02891642 Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid https://ClinicalTrials.gov/show/NCT02891642 Recruiting The First Affiliated Hospital with Nanjing Medical University 2021-02-28
NCT02421848 Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXA https://ClinicalTrials.gov/show/NCT02421848 Completed University of Sao Paulo 2012-05-31
NCT02163512 Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites https://ClinicalTrials.gov/show/NCT02163512 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2018-05-31
NCT01578226 Procalcitonin in Cirrhotic Patients at High Risk for Sepsis https://ClinicalTrials.gov/show/NCT01578226 Completed University of Modena and Reggio Emilia 2010-09-30
NCT03943316 Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies https://ClinicalTrials.gov/show/NCT03943316 Recruiting New Mexico Cancer Care Alliance 2020-12-31
NCT03737695 Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer https://ClinicalTrials.gov/show/NCT03737695 Recruiting Mayo Clinic 2020-11-05
NCT03650660 Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist https://ClinicalTrials.gov/show/NCT03650660 Recruiting Centre Hospitalier Universitaire de NÄ«mes 2020-05-31
NCT02857101 Calprotectin for Rapid Diagnostic Infection Spontaneous of Ascites https://ClinicalTrials.gov/show/NCT02857101 Recruiting Centre Hospitalier Universitaire de Besancon 2019-02-28
NCT03459378 Outcome After TIPS https://ClinicalTrials.gov/show/NCT03459378 Completed Medical University of Graz 2019-03-01
NCT02022150 Body Composition Analysis in Cirrhotic Undergoing Paracentesis https://ClinicalTrials.gov/show/NCT02022150 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2021-06-30
NCT00825877 Long-term Follow-up of HALT-C Sustained Virological Responders https://ClinicalTrials.gov/show/NCT00825877 Completed National Institutes of Health Clinical Center (CC) NA
NCT04131751 Application of Clinical Metagenomics in the Diagnosis of Ascites https://ClinicalTrials.gov/show/NCT04131751 Recruiting University Hospital Freiburg 2020-06-30
NCT02891369 Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites https://ClinicalTrials.gov/show/NCT02891369 Completed Groupe Hospitalier Paris Saint Joseph 2015-05-31
NCT00490217 Spontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome https://ClinicalTrials.gov/show/NCT00490217 Completed Tampere University NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03267615 VICIS - Vienna Cirrhosis Study https://ClinicalTrials.gov/show/NCT03267615 Recruiting Medical University of Vienna 2026-12-31
NCT03263598 Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites https://ClinicalTrials.gov/show/NCT03263598 Completed Keimyung University Dongsan Medical Center 2020-02-29
NCT03210298 International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) https://ClinicalTrials.gov/show/NCT03210298 Recruiting University of Magdeburg 2022-09-30
NCT02724683 Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter. https://ClinicalTrials.gov/show/NCT02724683 Recruiting Gdynia Oncology Center 2019-12-31
NCT04326946 International Alfapump Cohort Study https://ClinicalTrials.gov/show/NCT04326946 Recruiting Sequana Medical N.V. 2023-12-31